{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:41:00Z","timestamp":1763480460412,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bmcl.2021.128162","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T11:11:31Z","timestamp":1622286691000},"page":"128162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogs"],"prefix":"10.1016","volume":"46","author":[{"given":"Mark","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Gomez-Galeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Okolotowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley L.","family":"McKeithan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Mercola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Cashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bmcl.2021.128162_b0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1085\/jgp.201210899","article-title":"Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics","volume":"141","author":"Terrenoire","year":"2013","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.bmcl.2021.128162_b0010","doi-asserted-by":"crossref","unstructured":"2. Romero, K.; Woosley, R. L., Clinical Pharmacology of Antiarrhythmic Drugs. Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease (Fourth Edition) Chapter 18, Pages 343-364. https:\/\/doi.org\/10.1016\/B978-1-4557-0101-8.00018-7. 2013.","DOI":"10.1016\/B978-1-4557-0101-8.00018-7"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128162_b0015","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.tiv.2009.12.027","article-title":"Altered cytosolic Ca2+ dynamics in cultured guinea pig cardiomyocytes as an in vitro model to identify potential cardiotoxicants","volume":"24","author":"Qian","year":"2010","journal-title":"Toxicol In Vitro"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128162_b0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4065\/84.3.289","article-title":"Ventricular tachycardia and sudden cardiac death","volume":"84","author":"Koplan","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bmcl.2021.128162_b0025","doi-asserted-by":"crossref","unstructured":"Cerignoli, F.; Charlot, D.; Whittaker, R.; Ingermanson, R.; Gehalot, P.; Savchenko, A.; Gallacher, D. J.; Towart, R.; Price, J. H.; McDonough, P. M.; Mercola, M., High Throughput Measurement of Ca(2)(+) Dynamics for Drug Risk Assessment in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometry. J Pharmacol Toxicol Methods 2012, 66 (3), 246-256.","DOI":"10.1016\/j.vascn.2012.08.167"},{"key":"10.1016\/j.bmcl.2021.128162_b0030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fphys.2017.00766","article-title":"An automated platform for assessment of congenital and drug-induced arrhythmia with hiPSC-derived cardiomyocytes","volume":"8","author":"McKeithan","year":"2017","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128162_b0035","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1152\/physrev.00002.2005","article-title":"Molecular physiology of cardiac repolarization","volume":"85","author":"Nerbonne","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bmcl.2021.128162_b0040","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI119335","article-title":"Pharmacological targeting of long QT mutant sodium channels","volume":"99","author":"Wang","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmcl.2021.128162_b0045","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.RES.73.6.1061","article-title":"Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents","volume":"73","author":"Wang","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.bmcl.2021.128162_b0050","doi-asserted-by":"crossref","unstructured":"De Bellis, M.; De Luca, A.; Desaphy, J. F.; Carbonara, R.; Heiny, J. A.; Kennedy, A.; Carocci, A.; Cavalluzzi, M. M.; Lentini, G.; Franchini, C.; Camerino, D. C., Combined Modifications of Mexiletine Pharmacophores for New Lead Blockers of Na(v)1.4 Channels. Biophys J 2013, 104 (2), 344-354.","DOI":"10.1016\/j.bpj.2012.11.3830"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128162_b0055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0026-895X(24)23198-9","article-title":"Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels","volume":"57","author":"De Luca","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2021.128162_b0060","doi-asserted-by":"crossref","unstructured":"12. Wang, D. W.; Kiyosue, T.; Sato, T.; Arita, M., Comparison of the Effects of Class I Anti-Arrhythmic Drugs, Cibenzoline, Mexiletine and Flecainide, on the Delayed Rectifier K+ Current of Guinea-Pig Ventricular Myocytes. J Mol Cell Cardiol 1996, 28 (5), 893-903. PMID 8762029).","DOI":"10.1006\/jmcc.1996.0084"},{"key":"10.1016\/j.bmcl.2021.128162_b0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s004240050476","article-title":"Modulation by mexiletine of action potentials, L-type Ca current and delayed rectifier K current recorded from isolated rabbit atrioventricular nodal myocytes","volume":"434","author":"Mitcheson","year":"1997","journal-title":"Pflugers Arch"},{"issue":"22","key":"10.1016\/j.bmcl.2021.128162_b0070","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128162_b0075","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.ajem.2010.08.027","article-title":"Hemodialysis as an alternative treatment of mexiletine intoxication","volume":"29","author":"Akinci","year":"2011","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.bmcl.2021.128162_b0080","doi-asserted-by":"crossref","unstructured":"Roselli, M.; Carocci, A.; Budriesi, R.; Micucci, M.; Toma M.; Mannelli, L.D.C.; Lovece, A.; Catalano, A.; Cavalluzzi, M.M.; Bruno, C.; De Palma, A.; Contino, M.; Perrone, M.G.; Colabufo, N. A.; Chiarini, A.; Franchini, C.; Ghelardini, C.; Habtemariam, S.; Lentini, G.; Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues. Eur J Med Chem 2016, 121, 300-307.","DOI":"10.1016\/j.ejmech.2016.05.046"},{"key":"10.1016\/j.bmcl.2021.128162_b0085","doi-asserted-by":"crossref","unstructured":"Burridge, P. W.; Matsa, E.; Shukla, P.; Lin, Z. C.; Churko, J. M.; Ebert, A. D.; Lan, F.; Diecke, S.; Huber, B.; Mordwinkin, N. M.; Plews, J. R.; Abilez, O. J.; Cui, B.; Gold, J. D.; Wu, J. C., Chemically defined generation of human cardiomyocytes. Nat Methods 2014, 11 (8), 855-860.","DOI":"10.1038\/nmeth.2999"},{"key":"10.1016\/j.bmcl.2021.128162_b0090","doi-asserted-by":"crossref","unstructured":"Cunningham, T. J.; Yu, M. S.; McKeithan, W. L.; Spiering, S.; Carrette, F.; Huang, C. T.; Bushway, P. J.; Tierney, M.; Albini, S.; Giacca, M.; Mano, M.; Puri, P. L.; Sacco, A.; Ruiz-Lozano, P.; Riou, J. F.; Umbhauer, M.; Duester, G.; Mercola, M.; Colas, A. R., Id genes are essential for early heart formation. Genes Dev 2017, 31 (13), 1325-1338.","DOI":"10.1101\/gad.300400.117"},{"key":"10.1016\/j.bmcl.2021.128162_b0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cbpa.2016.06.003","article-title":"Small molecule fluorescent voltage indicators for studying membrane potential","volume":"33","author":"Miller","year":"2016","journal-title":"Curr Opin Chem Biol"},{"issue":"2","key":"10.1016\/j.bmcl.2021.128162_b0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/toxsci\/kfv201","article-title":"High throughput measurement of Ca++ dynamics in human stem cell-derived cardiomyocytes by kinetic image cytometery: a cardiac risk assessment characterization using a large panel of cardioactive and inactive compounds","volume":"148","author":"Lu","year":"2015","journal-title":"Toxicol Sci"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128162_b0105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/17460441.2012.682056","article-title":"HTS techniques for patch clamp-based ion channel screening \u2013 Advances and economy","volume":"7","author":"Farre","year":"2012","journal-title":"Expert Opin Drug Discov"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128162_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001258","article-title":"A novel and lethal de novo LQT-3 mutation in a newborn with distinct molecular pharmacology and therapeutic response","volume":"2","author":"Bankston","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2021.128162_b0115","unstructured":"US PCT Patent 2017\/035328, Compounds as inhibitors of sodium channels. J.R. Cashman, K. Okolotowicz and D. Ryan."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21003899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21003899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:41:02Z","timestamp":1760773262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21003899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":23,"alternative-id":["S0960894X21003899"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128162","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogs","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128162"}}